Detailed Segmentation-
By Service Type (Revenue, USD Bn, 2021 - 2033)
- Drug Discovery
- Preclinical studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb – IV
- Medical coding and writing
- Monitoring
- Clinical Data Management
- Others
By Therapeutic Application (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Cardiovascular Diseases
- Central Nervous System Diseases
- Infectious Diseases
- Immunological Disorders
- Respiratory Disorders
- Others
By Size of CROs (Revenue, USD Bn, 2021 - 2033)
- Small Size (Less than 100 employees)
- Medium Size (100-500 employees)
- Large Size (More than 500 employees)